Advertisement

Topics

Amgen up as Xgeva closes in on expanded indication

08:22 EDT 20 Jun 2017 | thePharmaLetter

US biotech Amgen closed 1.6% up on Monday at $165.09 after news of further progress relating to its monoclonal

Original Article: Amgen up as Xgeva closes in on expanded indication

NEXT ARTICLE

More From BioPortfolio on "Amgen up as Xgeva closes in on expanded indication"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...